Publications by authors named "O Haillot"
Purpose: In diseases where there is no real consensus regarding treatment modalities, promoting shared decision-making can contribute to improving safety and quality of care. This is the case in low- or intermediate-risk localized prostate cancer (PC) treatment. The aim of this study was to investigate the preferences guiding men's decisions regarding the characteristics of the treatment strategies for PC to help physicians adopt a more patient-centered approach.
View Article and Find Full Text PDFArticle Synopsis
- Candida nivariensis is a little-known fungus, part of the Candida glabrata complex, first identified in 2005 using DNA sequencing.* -
- A case of deep-seated infection from this fungus occurred in a 77-year-old man after prostate surgery, with initial tests misidentifying it as C. glabrata.* -
- Accurate identification was achieved through MALDI-TOF mass spectrometry, which proved effective, especially since the isolate was resistant to fluconazole, similar to around 20% of cases.*
Objective: To evaluate the effectiveness and tolerance of the AdVance Male Sling System for the treatment of male stress urinary incontinence in patients after prostatic surgery.
Methods: An international, observational, prospective, multicenter study was conducted on male patients with urinary incontinence after prostatic surgery. Patients underwent a 24-hour pad test with a threshold at 250 g.
Background: Genetic and nutritional factors have been linked to the risk of aggressive prostate cancer (PCa). The fatty acid (FA) composition of peri-prostatic adipose tissue (PPAT), which reflects the past FA intake, is potentially involved in PCa progression. We analysed the FA composition of PPAT, in correlation with the ethno-geographical origin of the patients and markers of tumour aggressiveness.
View Article and Find Full Text PDFBackground: Previous studies have suggested a link between metabolic syndrome (MetS) and prostate cancer (PCa). In the present study, we aimed to assess the association between MetS and markers of PCa aggressiveness on radical prostatectomy (RP).
Methods: All patients consecutively treated for PCa by RP in 6 academic institutions between August 2013 and July 2016 were included.